Search results
Results from the WOW.Com Content Network
Oxford Nanopore Technologies: 2 November 2012 [315] Nanopore sequencing: United Kingdom Sword Health: 2 November 2021 [316] ... IPO 5 United States Peloton: 4.0
Oxford Nanopore Technologies plc is a UK-based company which develops and sells nanopore sequencing products (including the portable DNA sequencer, MinION) for the direct, electronic analysis of single molecules. [2] [3] [4] It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. [5]
The London-listed firm, which was spun out from the University of Oxford and went public in 2021, expects full-year revenue to be 169 million pounds ($215.2 million), falling short of the ...
British technology company Oxford Nanopore said it hoped to reach break-even by the end of 2026, as it outlined plans to drive further growth in the life science research tools market and expand ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
For premium support please call: 800-290-4726 more ways to reach us
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California.Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.
The development of the OMI's focus creates a hub for machine learning and data analysis at Eagle House, the current home of the OMI and Man AHL's Oxford Research lab. [50] In December 2019, The University of Oxford and Man Group announced that funding support for the Oxford-Man Institute (OMI) had been agreed for a further five years. [51]